IL-10 production and IL-4 response (reported as anti-osteoclastogenic cytokines) were promoted and IL-7 response (reported as osteoclastogenic cytokines)26 was inhibited, indicating that osteoimmune system may regulate bone metabolism through an osteoclast inhibition microenvironment in T2D mice. This evidence concerns the gene IL7 and type 2 diabetes mellitus.